0001127602-13-014781.txt : 20130430 0001127602-13-014781.hdr.sgml : 20130430 20130430172322 ACCESSION NUMBER: 0001127602-13-014781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130426 FILED AS OF DATE: 20130430 DATE AS OF CHANGE: 20130430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patton Cynthia M CENTRAL INDEX KEY: 0001560565 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 13799135 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-04-26 0000318154 AMGEN INC AMGN 0001560565 Patton Cynthia M ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 SVP & CCO Common Stock 2013-04-26 4 F 0 50 108.66 D 15491 D Common Stock 2013-04-28 4 F 0 49 108.38 D 15442 D Common Stock 153.1876 I 401(k) Plan These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 132 RSUs which fully vest on 4/26/2014; 2,000 RSUs which vest in two equal annual installments of 1,000 each commencing 10/28/2013; 1,001 RSUs which vest in two installments of 493 and 508 on 4/25/2014 and 4/25/2015, respectively; 1,200 RSUs which vest in two equal installments of 396 each on 4/27/2014 and 4/27/2015 and one installment of 408 on 4/27/2016; 5,420 RSUs which vest in three installments of 1,788, 1,789 and 1,843 on 10/26/2014, 10/26/2015 and 10/26/2016, respectively; and 2,103 RSUs which vest in three installments of 693, 694 and 716 on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 82 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. /s/ Andrea Robinson, Attorney-in-Fact for Ms. Patton 2013-04-30